Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-03

Clinical Trial Update: A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept study evaluating tasimelteon vs placebo in travelers with jet lag disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tasimelteon (tasimelteon)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Jet Lag Disorder | Phase 2 | Status: COMPLETED | Results posted: 2021-11-03